From JPMA From the Chairman's Press Conference

On June 17, 2020, the JPMA "Chairman's Press Conference" was held at the Hotel Metropolitan Edmont (Chiyoda-ku, Tokyo) to explain the "JPMA Activity Policy for FY2020," "JPMA Proposals for the Creation of Infectious Drugs and Vaccines," "Proposals for the Framework Policy 2020," and "Progress of JPMA Policy Proposal 2019. The following items were explained.

The recent new type of coronavirus infection has quickly spread throughout the world, paralyzing economic and social activities in countries around the world and becoming a serious social problem on a global scale. In this situation, therapeutic drugs and vaccines are the key to early containment of the infection and economic recovery, and pharmaceutical companies are promoting research and development to create safe and effective new therapeutic drugs and vaccines, as well as utilizing existing drugs, for the treatment and prevention of this infectious disease.

Based on the experience of this pandemic, the JPMA has identified issues to be addressed in countermeasures against infectious diseases and formulated the "JPMA Proposal for the Creation of New Drugs and Vaccines for the Treatment of Infectious Diseases" to overcome future infectious disease outbreaks.

(From the June 17 JPMA President's Press Conference)